As of 10:50am ET
| -0.0131 / -1.55%|
The 1 analysts offering 12-month price forecasts for Navidea Biopharmaceuticals Inc have a median target of 2.40, with a high estimate of 2.40 and a low estimate of 2.40. The median estimate represents a +189.09% increase from the last price of 0.83.
The current consensus among 1 polled investment analysts is to Buy stock in Navidea Biopharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.